Hikma: a rising star on the FTSE All Share

Finding value in the FTSE All Share Index, Julius de Kempenaer, from RRG, drills down and discovers Hikma Pharmaceuticals as a stock worth thinking about.

Trade now

Live Hikma Pharmaceuticals prices

The information on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG Bank S.A. accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it and as such is considered to be a marketing communication.